TRIPTOLIDE DERIVATIVES AS IMMUNOMODULATOR AND ANTICANCER AGENTS

Details for Australian Patent Application No. 2003297211 (hide)

Owner PHARMAGENESIS, INC.

Inventors Musser, John H.; Dai, Dongcheng

Agent FB Rice

Pub. Number AU-A-2003297211

PCT Number PCT/US2003/0401

PCT Pub. Number WO2004/058246

Priority 60/434,203 17.12.02 US

Filing date 16 December 2003

Wipo publication date 22 July 2004

International Classifications

A61K 031/34 - having five-membered rings with one oxygen as the only ring hetero atom, e.g. isosorbide

C07D 307/77 Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom

Event Publications

6 May 2004 Complete Application Filed

  Priority application(s): 60/434,203 17.12.02 US

26 August 2004 Application Open to Public Inspection

  Published as AU-A-2003297211

9 July 2009 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

  This application lapsed under section 142(2)(d). Examination has been requested or an examination report has issued for this application. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2003297212-FLUORIDE IN SUPERCRITICAL FLUID FOR PHOTORESIST AND RESIDUE REMOVAL

2003297210-REFUSE VEHICLE CONTROL SYSTEM AND METHOD